Xylazine hydrochloride is an alpha-2 adrenergic agonist that is one of the most commonly used sedative-analgesic drugs in equine practice. It provides reliable sedation, muscle relaxation, and visceral analgesia, making it valuable for standing procedures, colic pain management, and as a pre-anesthetic agent. Xylazine was one of the first alpha-2 agonists used in veterinary medicine and remains a cornerstone of equine sedation protocols.

Overview

Xylazine works by stimulating alpha-2 adrenergic receptors in the central nervous system, reducing norepinephrine release and producing sedation, analgesia, and muscle relaxation. It also has peripheral effects including initial hypertension followed by sustained hypotension, bradycardia, and decreased cardiac output. In horses, xylazine provides approximately 20-30 minutes of sedation and analgesia at standard IV doses, with a somewhat longer but less predictable duration when given intramuscularly.

Horses are approximately 10 times more sensitive to xylazine than cattle. The equine-specific formulation (100 mg/mL) is used for horses, while the lower-concentration formulation (20 mg/mL) is intended for small animals and cattle.

Uses

  • Standing sedation — routine procedures such as dental work, wound care, clipping, farrier work
  • Chemical restraint — facilitating examination of fractious or anxious horses
  • Colic pain management — provides visceral analgesia; useful for initial colic assessment
  • Pre-anesthetic medication — commonly used before induction of general anesthesia
  • Combination sedation — frequently combined with butorphanol (opioid) for enhanced sedation and analgesia
  • Minor surgical procedures — castration (combined with other agents), laceration repair

Dosage

Administered by a veterinarian.

IndicationDoseRouteOnsetDuration
Light sedation0.3-0.5 mg/kgIV2-5 minutes15-20 minutes
Moderate-deep sedation0.5-1.1 mg/kgIV2-5 minutes20-40 minutes
Intramuscular sedation1.0-2.2 mg/kgIM10-20 minutes30-60 minutes
Colic analgesia0.3-0.5 mg/kgIV2-5 minutes15-30 minutes

Xylazine is commonly combined with butorphanol (0.01-0.02 mg/kg IV) for enhanced sedation and analgesia (a combination sometimes called “xylazine-butorphanol” or part of a “standing sedation cocktail”). The addition of butorphanol provides synergistic sedation with lower individual drug doses.

Reversal: Xylazine effects can be reversed with alpha-2 antagonists such as yohimbine (0.075 mg/kg IV) or atipamezole, though reversal is not commonly performed in routine equine practice.

Side Effects

Common (Expected pharmacologic effects)Serious (Contact Your Vet)
Head lowering, drooping lower lipProfound bradycardia
Ataxia (unsteadiness)Second-degree AV block (usually transient)
SweatingRespiratory depression
Penile prolapse (geldings/stallions)Severe hypotension
Decreased GI motilityRecumbency (especially with overdose or IM in dehydrated horses)
BradycardiaParadoxical excitation (rare)
Transient hyperglycemia and increased urinationParaphimosis (prolonged penile prolapse)

Cardiovascular effects: Xylazine causes an initial brief hypertensive phase followed by hypotension and bradycardia. Second-degree atrioventricular (AV) block is commonly seen and typically resolves as the drug wears off. These effects are generally well tolerated in healthy horses but may be significant in horses with cardiovascular compromise.

Kick risk: Horses may kick during the onset phase of sedation before they become fully sedated. Always stand to the side of the horse, not directly behind.

Drug Interactions

  • Butorphanol / other opioids: Synergistic sedation and analgesia. This is a commonly intended interaction.
  • Detomidine: Both are alpha-2 agonists; do not combine at full doses.
  • General anesthetics (ketamine, inhalants): Xylazine potentiates anesthetic effects; dose reductions of subsequent anesthetics are required.
  • Potentiated sulfonamide antibiotics (trimethoprim-sulfa): Rare reports of fatal cardiac arrhythmias with IV trimethoprim-sulfa in xylazine-sedated horses. Avoid rapid IV administration of trimethoprim-sulfa in sedated horses.
  • NSAIDs: No significant direct interaction; commonly used concurrently for colic management.

Contraindications

  • Horses with severe cardiovascular disease or heart block
  • Severely debilitated or dehydrated horses
  • Horses in late-stage pregnancy (may induce premature labor)
  • Known hypersensitivity to xylazine
  • Caution in horses with GI obstruction (further reduces motility)

Storage

  • Store at controlled room temperature, 59-86 degrees F (15-30 degrees C).
  • Protect from light.
  • Do not freeze.
  • Keep in a locked cabinet (controlled/monitored substance in many jurisdictions).

Frequently Asked Questions

How long does xylazine sedation last in horses? IV sedation typically lasts 20-40 minutes, depending on dose. IM sedation has a slower onset and may last 30-60 minutes. Deep sedation with higher doses lasts longer but carries more cardiovascular risk.

Is xylazine the same thing that is in the news as a street drug? Xylazine has been identified as an adulterant in illicit drug supplies. As a result, some states have placed xylazine under additional regulatory controls. Veterinary use remains legal and appropriate. Your veterinarian follows all DEA and state guidelines for its storage and use.

Can my horse eat after being sedated with xylazine? Wait until the horse is fully alert and coordinated before offering food or water. The swallowing reflex and GI motility are reduced during sedation, increasing the risk of choke or aspiration.

Why does my gelding’s penis hang down after sedation? Penile prolapse is a normal pharmacologic effect of alpha-2 agonists. It typically resolves as sedation wears off. Prolonged prolapse (paraphimosis) is uncommon but should be reported to your veterinarian.

This information is for educational purposes only and does not replace professional veterinary advice. Always consult your veterinarian before administering any medication to your horse.